Items tagged with Treatment
India plans to expand access to new TB drug (post)
The Government of India is planning to increase access to a new drug for drug-resistant TB after a landmark court ruling. Dinesh C Sharma reports from New Delhi.
Nix-TB trial: Good results for three-drug regimen against XDR-TB (BPaL) (post)
A regimen of three oral drugs given for six months was enough to clear extensively drug-resistant tuberculosis (XDR-TB) in 29 of the first 31 people to have completed the treatment course, Dr Francesca Conradie of Sizwe Tropical Disease Hospital, Johannesburg, told the 2017 Conference on Retroviruses and Opportunistic Infections (CROI). If the results are replicated in a larger population, the findings could revolutionise the prospects for treating not just XDR-TB, but also the more severe cases of MDR-TB (multidrug-resistant tuberculosis).
BPaMZ and BPaL: Two new drug therapies might cure every form of TB (post)
Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat.
NC-005 trial: Shorter treatment for MDR-TB in sight (BPaMZ) (post)
Shorter more effective treatment for drug-sensitive and drug-resistant tuberculosis (TB) is on the horizon.
Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant TB cases diagnosed in a routine operational setting? (post)
Abstract
Georgia: endTB partnership launches clinical trial to target toughest strains of TB (post)
TBILISI (Georgia), 6 March 2017 – Médecins Sans Frontières (MSF), Partners In Health (PIH) and other leading medical organizations have launched a major clinical trial which seeks to revolutionize treatment for the toughest strains of tuberculosis (TB), the world’s leading infectious disease killer. The first patient started treatment in Georgia last week.
South Africa scores new medicine worth millions – for free (post)
Drugmaker Otsuka Pharmaceutical won’t charge South Africa for using its new tuberculosis (TB) drug in a pilot programme, but South Africa’s free deal is unlikely to last.
Despite 2 ‘miracle’ drugs, TB patient dies after long battle (post)
A 19-year-old tuberculosis (TB) patient who was among the first in India to receive both Bedaquiline and Delamanid drugs died last month after battling the infection for a prolonged period. In her final days, she was on oxygen support after doctors labelled her as “therapeutically incurable”.
DR-TB STAT on WHO bedaquiline recommendations (post)
The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) issued a Bedaquiline Bulletin.
Page 29 of 108 · Total posts: 0
←First 28 29 30 Last→